Novartis reported $36.95B in Current Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Amgen AMGN:US USD 24.06B 4.74B
AstraZeneca AZN:LN USD 20.22B 693M
Astrazeneca AZN:US USD 20.22B 693M
Biogen BIIB:US USD 9.77B 24.9M
Bristol Myers Squibb BMY:US USD 26.8B 3.39B
Canopy Growth Corp WEED:CN CAD 1.54B 55.4M
Catalent CTLT:US USD 2.7B 218M
Corcept Therapeutics CORT:US USD 452.4M 33.36M
Eli Lilly And LLY:US USD 17.64B 524.7M
Endo International Ordinary Shares ENDP:US USD 2.05B 145.74M
Gilead Sciences GILD:US USD 13.9B 723M
GlaxoSmithKline GSK:LN GBP 20.25B 33.94B
Glaxosmithkline GSK:US GBP 20.25B 33.94B
Horizon Pharma HZNP:US USD 3.41B 208.92M
Lannett LCI:US USD 264.66M 25.46M
Novartis NOVN:VX USD 36.95B 1.19B
Pacira Pharmaceuticals PCRX:US USD 533.41M 7.2M
Perrigo Ordinary Shares PRGO:US USD 2.58B 68.2M
Phibro Animal Health PAHC:US USD 570.08M 3.85M
Prestige Brands PBH:US USD 336.65M 12.04M
Roche Holding ROG:VX 30.32B 5.31B
Supernus Pharmaceuticals SUPN:US USD 663.89M 38.77M
Teva Pharmaceutical Industries TEVA:US USD 11.45B 711M
Valeant Pharmaceuticals VRX:CN USD 4.01B 1.41B
Zoetis ZTS:US USD 6.55B 100M